Dr. Inman Discusses the Biology of Bladder Cancer

Brant Inman, MD
Published: Tuesday, Oct 03, 2017



Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center, discusses the biology of bladder cancer.

Bladder cancer is being better understood with the utilization of genome sequencing and RNA sequencing, both of which have allowed for this disease to be categorized into several different molecular subtypes.

Tests to check for these subtypes will become important in the future, Inman says, as it will help guide treatment for patients.
 
SELECTED
LANGUAGE


Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center, discusses the biology of bladder cancer.

Bladder cancer is being better understood with the utilization of genome sequencing and RNA sequencing, both of which have allowed for this disease to be categorized into several different molecular subtypes.

Tests to check for these subtypes will become important in the future, Inman says, as it will help guide treatment for patients.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Community Practice Connections™: 2nd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing ApplicationFeb 28, 20192.0
Publication Bottom Border
Border Publication
x